This is a reply to Toxins 2014, 6(4), 1362-1363.

Toxins 2014, 6(4), 1364-1365; doi:10.3390/toxins6041364
Reply

Response to John G. Brock-Utne. Comment on Hurley, J.C. Towards Clinical Application of Anti-endotoxin Antibodies; A Re-Appraisal of the Disconnect

1,2,3email
Received: 8 April 2014; Accepted: 9 April 2014 / Published: 11 April 2014
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: I appreciate the thoughtful comments from Dr. Brock-Utne [1] on my recent review of the disconnect between animal studies and clinical experience with anti-endotoxemia therapies [2].
PDF Full-text Download PDF Full-Text [136 KB, uploaded 11 April 2014 09:23 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Hurley, J.C. Response to John G. Brock-Utne. Comment on Hurley, J.C. Towards Clinical Application of Anti-endotoxin Antibodies; A Re-Appraisal of the Disconnect. Toxins 2014, 6, 1364-1365.

AMA Style

Hurley JC. Response to John G. Brock-Utne. Comment on Hurley, J.C. Towards Clinical Application of Anti-endotoxin Antibodies; A Re-Appraisal of the Disconnect. Toxins. 2014; 6(4):1364-1365.

Chicago/Turabian Style

Hurley, James C. 2014. "Response to John G. Brock-Utne. Comment on Hurley, J.C. Towards Clinical Application of Anti-endotoxin Antibodies; A Re-Appraisal of the Disconnect." Toxins 6, no. 4: 1364-1365.

Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert